(CLNO, ISIL, BANR, BRKL) Stock Updates by CRWESelect.com
HITT, CLNO, ISIL, ELNK, - PennyToBuck.com Stock Report!
ISIL, CLNO, VOXX, ORFG, VSNT - Stock Update From DoubleInStocks.com!
(CFNL, DLKM, SPSC, GRHU, ISIL) Market Update From PennyOmega.com
ISIL, AVOT.PK, CCOI, CRWE.OB, EEI, - Intersil Corporation, American Video Teleconferencing Corp., Cogent Communications Group
Intersil Corporation (NASDAQ:ISIL) reported the availability of the ISL76321, a unique Serializer/Deserializer (SerDes) interface IC targeting automotive rear view safety systems. This single chip transceiver solution simplifies system design by sending video data, bi-directional control information and power across a single shielded twisted pair (STP) cable.
ROK, PWRM, BGP, ISIL - DoubleInStocks.com Stock Report! Nov 2nd 2010
Power3 Medical Products Inc (OTCBB:PWRM.OB) is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig's disease).
ISIL, CRWE, FITB, PBCT - Weekend Stock Watch For: Intersil Corp, Crown Equity Holdings, Fifth Third Bancorp, People’s United Fin
Companies Kicking Conflicts - MGLT, CINF, ISIL, ABTL - DrStockPick.com
ISIL, EVCA, IILG, IBCA - Stock Alerts! from Stock-Pr.com - Intersil, Evcarco, Interval Leisure Group, Intervest Bancshares
FREE Daily Stock Alerts From Stock-PR.com
Evcarco, Inc. (EVCA.OB)
EVCA is pleased to present to the shareholders of EVCARCO the latest update from its Italian manufacturer TAZZARI.
FROM TAZZARI GROUP ITALY www.tazzari-zero.com
Intersections Inc. Ranked Best In Class For Identity Theft Protection! DrStockPick Brings News On INTX, ISIL, PROT and IPG.
PROTEONOMIX, INC. (OTC.BB:PROT), a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, reports that Mr. Michael Cohen, Chairman and CEO, is scheduling a multi-city European road trip to create additional awareness of the Proteonomix, Inc. investment opportunity to institutional investors.